| Zacks Company Profile for Sinovac Biotech, Ltd. (SVA : NSDQ) |
|
|
| |
| • Company Description |
| Sonovac Biotech Ltd. specializes in the research, development, commercialization, and sales of human vaccines for infectious illnesses such as hepatitis A and hepatitis B, influenza, `SARS`, and avian flu. Sinovac is one of the leading emerging biotechnology companies in China.
Number of Employees: |
|
|
| |
| • Price / Volume Information |
| Yesterday's Closing Price: $6.47 |
Daily Weekly Monthly
 |
| 20 Day Moving Average: 0 shares |
| Shares Outstanding: 99.64 (millions) |
| Market Capitalization: $644.66 (millions) |
| Beta: 0.56 |
| 52 Week High: $ |
| 52 Week Low: $ |
| Short Interest Ratio: |
| |
% Price Change |
% Price Change Relative to S&P 500 |
| 4 Week |
0.00% |
-2.62% |
| 12 Week |
0.00% |
-4.15% |
| Year To Date |
0.00% |
-12.59% |
|
|
|
|
| |
| • Address & Contact Information |
| Street Address |
Phone / Fax |
Email Address |
Web URL |
NO. 39 SHANGDI XI ROAD HAIDIAN DISTRICT
-
BEIJING,F4 100085
CHN |
ph: 86-10-5693-1800
fax: 86-10-5693-1800 |
ir@sinovac.com |
http://www.sinovac.com |
|
|
| |
| • General Corporate Information |
Officers
Weidong Yin - Chairman; President; Chief Executive Officer
Qiang Gao - Chief Operating Officer; Vice President
Nan Wang - Chief Financial Officer; Vice President
Simon Anderson - Independent Director
Yuk Lam Lo - Independent Director
|
|
Peer Information
Sinovac Biotech, Ltd. (CORR.)
Sinovac Biotech, Ltd. (RSPI)
Sinovac Biotech, Ltd. (CGXP)
Sinovac Biotech, Ltd. (BGEN)
Sinovac Biotech, Ltd. (GTBP)
Sinovac Biotech, Ltd. (RGRX)
|
|
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED-BIOMED/GENE
Sector: Medical
CUSIP: P8696W104
SIC: 2834
|
|
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: -
Next Expected EPS Date: -
|
|
Share - Related Items
Shares Outstanding: 99.64
Most Recent Split Date: (:1)
Beta: 0.56
Market Capitalization: $644.66 (millions)
|
|
|
|
|
| |
| • EPS Information |
• Dividend Information |
| Analyst Coverage: No |
Dividend Yield: 0.00% |
| Current Fiscal Quarter EPS Consensus Estimate: $ |
Indicated Annual Dividend: $0.00 |
| Current Fiscal Year EPS Consensus Estimate: $ |
Payout Ratio: |
| Number of Estimates in the Fiscal Year Consensus: |
Change In Payout Ratio: |
| Estmated Long-Term EPS Growth Rate: % |
Last Dividend Paid: NA - $0.00 |
| Next EPS Report Date: - |
|
|
|
| |
